UPRIGHT, a resilience-based intervention to promote mental well-being in schools: study rationale and methodology for a European randomized controlled trial.

Adolescence Health-promoting school Mental disorders Mental health education Mental well-being Resilience Whole school approach

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
29 Oct 2019
Historique:
received: 16 09 2019
accepted: 07 10 2019
entrez: 31 10 2019
pubmed: 31 10 2019
medline: 22 1 2020
Statut: epublish

Résumé

Adolescence is crucial period for laying the foundations for healthy development and mental well-being. The increasing prevalence of mental disorders amongst adolescents makes promotion of mental well-being and prevention interventions at schools important. UPRIGHT (Universal Preventive Resilience Intervention Globally implemented in schools to improve and promote mental Health for Teenagers) is designed as a whole school approach (school community, students and families) to promote a culture of mental well-being and prevent mental disorders by enhancing resilience capacities. The present article aims at describing the rationale, conceptual framework, as well as methodology of implementation and evaluation of the UPRIGHT intervention. UPRIGHT project is a research and innovation project funded by the European Union's Horizon 2020 Research and Innovation programme under grant agreement No. 754919 (Duration: 48 months). The theoretical framework has been developed by an innovative and multidisciplinary approach using a co-creation process inside the UPRIGHT Consortium (involving seven institutions from Spain, Italy, Poland, Norway, Denmark, and Iceland). Resulted is the UPRIGHT programme with 18 skills related to 4 components: Mindfulness, Coping, Efficacy and Social and Emotional Learning. Among the five Pan-European regions, 34 schools have been currently involved (17 control; 17 intervention) and around 6000 adolescents and their families are foreseen to participate along a 3-year period of evaluation. Effectiveness of the intervention will be evaluated as a randomized controlled trial including quantitative and qualitative analysis in the five Pan-European regions representative of the cultural and socioeconomic diversity. The cost-effectiveness assessment will be performed by simulation modelling methods. We expect a short- to medium-term improvement of mental well-being in adolescents by enhancing resilience capacities. The study may provide robust evidence on intrapersonal, familiar and social environmental resilience factors promoting positive mental well-being. ClinicalTrials.gov Identifier: NCT03951376 . Registered 15 May 2019.

Sections du résumé

BACKGROUND BACKGROUND
Adolescence is crucial period for laying the foundations for healthy development and mental well-being. The increasing prevalence of mental disorders amongst adolescents makes promotion of mental well-being and prevention interventions at schools important. UPRIGHT (Universal Preventive Resilience Intervention Globally implemented in schools to improve and promote mental Health for Teenagers) is designed as a whole school approach (school community, students and families) to promote a culture of mental well-being and prevent mental disorders by enhancing resilience capacities. The present article aims at describing the rationale, conceptual framework, as well as methodology of implementation and evaluation of the UPRIGHT intervention.
METHODS METHODS
UPRIGHT project is a research and innovation project funded by the European Union's Horizon 2020 Research and Innovation programme under grant agreement No. 754919 (Duration: 48 months). The theoretical framework has been developed by an innovative and multidisciplinary approach using a co-creation process inside the UPRIGHT Consortium (involving seven institutions from Spain, Italy, Poland, Norway, Denmark, and Iceland). Resulted is the UPRIGHT programme with 18 skills related to 4 components: Mindfulness, Coping, Efficacy and Social and Emotional Learning. Among the five Pan-European regions, 34 schools have been currently involved (17 control; 17 intervention) and around 6000 adolescents and their families are foreseen to participate along a 3-year period of evaluation. Effectiveness of the intervention will be evaluated as a randomized controlled trial including quantitative and qualitative analysis in the five Pan-European regions representative of the cultural and socioeconomic diversity. The cost-effectiveness assessment will be performed by simulation modelling methods.
DISCUSSION CONCLUSIONS
We expect a short- to medium-term improvement of mental well-being in adolescents by enhancing resilience capacities. The study may provide robust evidence on intrapersonal, familiar and social environmental resilience factors promoting positive mental well-being.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov Identifier: NCT03951376 . Registered 15 May 2019.

Identifiants

pubmed: 31664974
doi: 10.1186/s12889-019-7759-0
pii: 10.1186/s12889-019-7759-0
pmc: PMC6820972
doi:

Banques de données

ClinicalTrials.gov
['NCT03951376']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1413

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 754919

Investigateurs

Maider Mateo (M)
Igor Larrañaga (I)
Iñaki Zorrilla (I)
Patricia Pérez Martínez (P)
Rosa Maimone (R)
Solveig Karlsdottir (S)
Sigrun Danielsdottir (S)
Alda Ingibergsdottir (A)
Hrefna Palsdottir (H)
Unnur B Arnfjord (UB)

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Lancet. 2015 Apr 18;385(9977):1536-44
pubmed: 25579833
Lancet Psychiatry. 2015 Nov;2(11):1036-42
pubmed: 26404415
Health Promot Int. 2011 Dec;26 Suppl 1:i29-69
pubmed: 22079935
J Adolesc Health. 2002 Mar;30(3):196-204
pubmed: 11869927
Int J Epidemiol. 2007 Aug;36(4):703-7
pubmed: 17646185
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
BMC Public Health. 2012 Aug 21;12:684
pubmed: 22908894
Schizophr Bull. 2016 Mar;42(2):344-57
pubmed: 26371339
J Adolesc. 2017 Jun;57:74-89
pubmed: 28384523
Soc Psychiatry Psychiatr Epidemiol. 2018 Jul;53(7):647-662
pubmed: 29752493
Lancet. 2011 Oct 22;378(9801):1515-25
pubmed: 22008427
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
J Child Psychol Psychiatry. 2016 Dec;57(12):1337-1359
pubmed: 27445203
Behav Res Ther. 2010 Jan;48(1):68-73
pubmed: 19786274
Child Adolesc Ment Health. 2013 Sep;18(3):158-164
pubmed: 32847253
Am Psychol. 2001 Mar;56(3):227-38
pubmed: 11315249

Auteurs

Carlota Las Hayas (C)

Kronikgune Institute for Health Services Research, Torre del BEC, Ronda de Azkue 1, 48902, Barakaldo, Bizkaia, Basque Country, Spain. clashayas@kronikgune.org.

Irantzu Izco-Basurko (I)

Kronikgune Institute for Health Services Research, Torre del BEC, Ronda de Azkue 1, 48902, Barakaldo, Bizkaia, Basque Country, Spain.

Ane Fullaondo (A)

Kronikgune Institute for Health Services Research, Torre del BEC, Ronda de Azkue 1, 48902, Barakaldo, Bizkaia, Basque Country, Spain.

Silvia Gabrielli (S)

Bruno Kessler Foundation, Trento, Italy.

Antoni Zwiefka (A)

Lower Silesia Voivodeship Marshal Office, Wrocław, Poland.

Odin Hjemdal (O)

Norwegian University of Science and Technology, Trondheim, Norway.

Dora G Gudmundsdottir (DG)

Directorate of Health in Iceland, Reykjavík, Iceland.

Hans Henrik Knoop (HH)

Aarhus University, Aarhus, Denmark.

Anna S Olafsdottir (AS)

University of Iceland, School of Education, Reykjavík, Iceland.

Valeria Donisi (V)

Bruno Kessler Foundation, Trento, Italy.

Sara Carbone (S)

Bruno Kessler Foundation, Trento, Italy.

Silvia Rizzi (S)

Bruno Kessler Foundation, Trento, Italy.

Iwona Mazur (I)

Daily Centre for Psychiatry and Speech Disorders, Wrocław, Poland.
Wroclaw Medical University, Wrocław, Poland.

Anna Krolicka-Deregowska (A)

Daily Centre for Psychiatry and Speech Disorders, Wrocław, Poland.

Roxanna Morote (R)

Norwegian University of Science and Technology, Trondheim, Norway.

Frederick Anyan (F)

Norwegian University of Science and Technology, Trondheim, Norway.

Mette Marie Ledertoug (MM)

Aarhus University, Aarhus, Denmark.

Nina Tange (N)

Aarhus University, Aarhus, Denmark.

Ingibjorg Kaldalons (I)

University of Iceland, School of Education, Reykjavík, Iceland.

Bryndis Jona Jonsdottir (BJ)

University of Iceland, School of Education, Reykjavík, Iceland.

Ana González-Pinto (A)

University Hospital Alava-Santiago, Spanish Society of Biological Psychiatry (CIBERSAM), Vitoria, Spain.

Itziar Vergara (I)

Research Unit. AP-OSIs Gipuzkoa, Mondragón, Spain.

Nerea González (N)

Kronikgune Institute for Health Services Research, Torre del BEC, Ronda de Azkue 1, 48902, Barakaldo, Bizkaia, Basque Country, Spain.
Hospital Galdakao-Usansolo, Health Services Research on Chronic Patients Network- REDISSEC, Galdakao, Spain.

Javier Mar Medina (J)

Clinical Management Unit, Hospital Alto Deba, Mondragón, Spain.

Esteban de Manuel Keenoy (E)

Kronikgune Institute for Health Services Research, Torre del BEC, Ronda de Azkue 1, 48902, Barakaldo, Bizkaia, Basque Country, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH